相关实验视频
Updated: Jan 16, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
906
肥胖患者的草药和生活方式改变:一个单一中心,回顾性,观察性研究
Minwoo Bang1,2, Suyong Shin3,4, Jungsang Kim4,5
1Daeat Korean Medicine Clinic Seoul, 121, Dosan-daero, Gangnam-gu, Seoul 06035, Republic of Korea.
Pharmaceuticals (Basel, Switzerland)
|September 27, 2025
概括
综合韩国医学治疗 (IKMT),结合草药和生活方式的修改,显示了有效和安全的减肥减肥的承诺. 这种方法导致了显著的体重减轻和改善的健康标志物,没有严重的不良事件.
科学领域:
- 综合医学是一个整体的医学.
- 肥胖管理 肥胖管理
- 韩国传统医学 韩国传统医学
背景情况:
- 传统的肥胖治疗有不良事件的风险.
- 需要安全有效的减肥策略.
- 综合韩国医学治疗 (IKMT) 结合了草药 (HM) 和生活方式修改 (LM).
研究的目的:
- 评估IKMT对肥胖患者减肥的治疗反应和安全性.
- 用生物电阻分析 (BIA) 和血压 (BP) 指数来评估IKMT的有效性.
- 通过监测不良事件 (AE) 来分析安全概况.
主要方法:
- 从3161名门诊患者 (2021年7月至2023年5月) 的电子医疗记录的回顾性审查.
- 使用BIA和BP指数对治疗反应进行评估.
- 通过AE分析进行安全评估,重点关注最佳情况子组 (n=24).
主要成果:
- 在所有参与者中,平均体重减轻8.02公斤 (8.71%);2146人实现了≥5%的体重减轻.
- 最好的情况子组 (n=24) 实现了平均体重减轻23.02公斤,达到BMI<23公斤/m2.
- 在21名患者中观察到BP指数的统计学显著下降;即使在长期使用HM,也没有报告严重的副作用.
结论:
- 结合营养师领导的LM,IKMT是一种安全有效的肥胖管理方法.
- 这项研究是韩国首次调查IKMT与专业合作对肥胖的研究.
- 需要进一步的前性研究来确认发现并标准化治疗方案.
相关概念视频
Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
247
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
247
Hypertension IV: Drug Therapy and Lifestyle Modifications
624
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
624
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225

